| Company Name: |
Zhengzhou Granlen Sciences, ltd.
|
| Tel: |
0371-85513397 +86-18610099868 |
| Email: |
info@granlen.com |
| Products Intro: |
Product Name:2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine
CAS:2389988-71-8
Purity: 95% HPLC Package:根据客户需要包装 Remarks:GL103133
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy ? guanosine
CAS:2389988-71-8
Package:5mg;10mg;25mg
|
2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine manufacturers
|
| | 2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine Basic information |
| | 2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine Chemical Properties |
| Boiling point | 689.2±65.0 °C(Predicted) | | density | 1.55±0.1 g/cm3(Predicted) | | pka | 2.09±0.20(Predicted) |
| | 2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine Usage And Synthesis |
| Uses | 2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 2’,3’-Di-O-acetyl-8-benzyloxy-3’-deoxy guanosine Preparation Products And Raw materials |
|